International Research-to-Practice Conference “Actual problems of HIV infection. Children and HIV” took place in St. Petersburg on May 14-15. The event was attended by Russian and foreign experts in the field of fighting the serious disease, including those from Switzerland and Italy.
Particular attention was paid to the issues of providing a wide range of assistance and support to HIV-infected children, from prevention to treatment and rehabilitation.
Pharmasyntez’s representatives have actively participated in discussions and informing specialists, doctors, members of public organizations on medical products produced by the Group, production quality, dosing regimens for antiretroviral therapy, and recent scientific developments in the field of treatment and prevention of HIV infection in patients of different age groups.
Pharmasyntez Group of Companies produces over 45% volumes of antiretroviral drugs in the Russian market, thus implementing the state import substitution program. Russian pharmaceuticals significantly reduce the cost of annual course of therapy and save thousands of lives. Every second tablet taken by a HIV-infected patient is produced by Pharmasyntez.
Pharmasyntez also acknowledges that, in fighting against HIV and AIDS, it is necessary to support the promotion of programs intended to inform the population on this infectious disease. The company actively supports various conferences, all-Russian actions aimed at the fight against HIV/AIDS, permanently collaborates with the AIDS Centers in different Russian cities, and conducts joint charity projects.